Cowen and Company’s NorthView Acquisition Corporation Rights NVACR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-670,950
Closed -$34.3K 524
2024
Q3
$34.3K Sell
670,950
-675
-0.1% -$52 ﹤0.01% 384
2024
Q2
$68.7K Buy
671,625
+12,691
+2% +$1.67K ﹤0.01% 291
2024
Q1
$98.8K Sell
658,934
-145,323
-18% -$16.3K ﹤0.01% 294
2023
Q4
$70.1K Buy
804,257
+72,975
+10% +$8.39K ﹤0.01% 257
2023
Q3
$124K Sell
731,282
-157,833
-18% -$21.1K 0.01% 241
2023
Q2
$124K Buy
889,115
+119,565
+16% +$19.6K 0.01% 232
2023
Q1
$131K Sell
769,550
-321,447
-29% -$54.2K 0.02% 175
2022
Q4
$188K Sell
1,090,997
-147,829
-12% -$17.1K 0.02% 180
2022
Q3
$93K Buy
1,238,826
+24,000
+2% +$2.32K 0.01% 225
2022
Q2
$142K Buy
1,214,826
+98,573
+9% +$12.9K 0.01% 221
2022
Q1
$157K Buy
+1,116,253
New +$188K 0.02% 248

Other funds holding NVACR

Cowen and Company's NVACR Position: Q4 2024 in Review

Cowen and Company sold out of NorthView Acquisition Corporation Rights (NVACR) in Q4 2024, closing a stake of 670,950 shares — an estimated $34.3K sold.

Cowen and Company first reported a position in NVACR in Q1 2022 and held it in 11 quarters. The position peaked at $188K in Q4 2022. 5 funds tracked by Wall St. Rank hold NVACR as of Q4 2024.

  • Cowen and Company reported no remaining NorthView Acquisition Corporation Rights position as of Q4 2024 after selling out during the quarter.
  • Cowen and Company sold 670,950 NorthView Acquisition Corporation Rights shares in Q4 2024, an estimated $34.3K.
  • Cowen and Company first reported a position in NorthView Acquisition Corporation Rights in Q1 2022 and held it in 11 quarters.
  • Cowen and Company's NorthView Acquisition Corporation Rights position peaked at $188K in Q4 2022.
  • 5 funds tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q4 2024.

Based on Cowen and Company's 13F filing for Q4 2024.